GenomeNet

Database: UniProt
Entry: O14442
LinkDB: O14442
Original site: O14442 
ID   CP51_UNCNE              Reviewed;         524 AA.
AC   O14442; O14422;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   27-MAR-2024, entry version 101.
DE   RecName: Full=Eburicol 14-alpha-demethylase;
DE            EC=1.14.14.154;
DE   AltName: Full=CYPLI;
DE   AltName: Full=Cytochrome P450 51;
DE   AltName: Full=Cytochrome P450-14DM;
DE   AltName: Full=Cytochrome P450-LIA1;
DE   AltName: Full=Sterol 14-alpha demethylase;
GN   Name=CYP51;
OS   Uncinula necator (Grape powdery mildew).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Leotiomycetes;
OC   Erysiphales; Erysiphaceae; Erysiphe.
OX   NCBI_TaxID=52586;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT PHE-136.
RC   STRAIN=FPE11;
RX   PubMed=9300816; DOI=10.1016/s0378-1119(97)00141-8;
RA   Delye C., Laigret F., Corio-Costet M.-F.;
RT   "Cloning and sequence analysis of the eburicol 14alpha-demethylase gene of
RT   the obligate biotrophic grape powdery mildew fungus.";
RL   Gene 195:29-33(1997).
RN   [2]
RP   SEQUENCE REVISION TO 515-517.
RA   Delye C., Laigret F., Corio-Costet M.-F.;
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   MOLECULAR BASIS OF FUNGICIDE RESISTANCE.
RC   STRAIN=PAZ11;
RX   PubMed=9251183; DOI=10.1128/aem.63.8.2966-2970.1997;
RA   Delye C., Laigret F., Corio-Costet M.-F.;
RT   "A mutation in the 14 alpha-demethylase gene of Uncinula necator that
RT   correlates with resistance to a sterol biosynthesis inhibitor.";
RL   Appl. Environ. Microbiol. 63:2966-2970(1997).
CC   -!- FUNCTION: Sterol 14alpha-demethylase that plays a critical role in the
CC       third module of ergosterol biosynthesis pathway, being ergosterol the
CC       major sterol component in fungal membranes that participates in a
CC       variety of functions (By similarity). The third module or late pathway
CC       involves the ergosterol synthesis itself through consecutive reactions
CC       that mainly occur in the endoplasmic reticulum (ER) membrane (By
CC       similarity). In filamentous fungi, during the initial step of this
CC       module, lanosterol (lanosta-8,24-dien-3beta-ol) can be metabolized to
CC       eburicol (By similarity). Sterol 14alpha-demethylase catalyzes the
CC       three-step oxidative removal of the 14alpha-methyl group (C-32) of both
CC       these sterols in the form of formate, and converts eburicol and
CC       lanosterol to 14-demethyleburicol (4,4,24-trimethylergosta-8,14,24(28)-
CC       trienol) and 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol,
CC       respectively, which are further metabolized by other enzymes in the
CC       pathway to ergosterol (By similarity). Can also use substrates not
CC       intrinsic to fungi, such as 24,25-dihydrolanosterol (DHL), producing
CC       4,4-dimethyl-8,14-cholestadien-3-beta-ol, but at lower rates than the
CC       endogenous substrates (By similarity). {ECO:0000250|UniProtKB:P10613,
CC       ECO:0000250|UniProtKB:P10614, ECO:0000250|UniProtKB:Q4WNT5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-methyl steroid + 3 O2 + 3 reduced [NADPH--
CC         hemoprotein reductase] = a Delta(14) steroid + formate + 4 H(+) + 4
CC         H2O + 3 oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:54028, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:138029, ChEBI:CHEBI:138031; EC=1.14.14.154;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54029;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-methyl steroid + O2 + reduced [NADPH--hemoprotein
CC         reductase] = a 14alpha-hydroxymethyl steroid + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68060, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:138029, ChEBI:CHEBI:176901;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68061;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-hydroxymethyl steroid + O2 + reduced [NADPH--
CC         hemoprotein reductase] = a 14alpha-formyl steroid + H(+) + 2 H2O +
CC         oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68064,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:176901, ChEBI:CHEBI:176902;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68065;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-formyl steroid + O2 + reduced [NADPH--hemoprotein
CC         reductase] = a Delta(14) steroid + formate + 2 H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68068, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:15740,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:138031,
CC         ChEBI:CHEBI:176902; Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68069;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lanosterol + 3 O2 + 3 reduced [NADPH--hemoprotein reductase] =
CC         4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 4
CC         H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:25286, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:16521, ChEBI:CHEBI:17813,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; EC=1.14.14.154;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25287;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lanosterol + O2 + reduced [NADPH--hemoprotein reductase] = 32-
CC         hydroxylanosterol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:75103, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16521, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:166806; Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75104;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-hydroxylanosterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 32-oxolanosterol + H(+) + 2 H2O + oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:75107, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:166681, ChEBI:CHEBI:166806;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75108;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-oxolanosterol + O2 + reduced [NADPH--hemoprotein reductase]
CC         = 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 2
CC         H(+) + H2O + oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:75111, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:17813, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:166681;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75112;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eburicol + 3 O2 + 3 reduced [NADPH--hemoprotein reductase] =
CC         14-demethyleburicol + formate + 4 H(+) + 4 H2O + 3 oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:75439, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:15740, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:70315, ChEBI:CHEBI:194330;
CC         Evidence={ECO:0000250|UniProtKB:P10613};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75440;
CC         Evidence={ECO:0000250|UniProtKB:P10613};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eburicol + O2 + reduced [NADPH--hemoprotein reductase] = 32-
CC         hydroxyeburicol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:75427, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:70315,
CC         ChEBI:CHEBI:194328; Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75428;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-hydroxyeburicol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 32-oxoeburicol + H(+) + 2 H2O + oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:75431, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:194328, ChEBI:CHEBI:194329;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75432;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-oxoeburicol + O2 + reduced [NADPH--hemoprotein reductase] =
CC         14-demethyleburicol + formate + 2 H(+) + H2O + oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:75435, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:15740, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:194329, ChEBI:CHEBI:194330;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75436;
CC         Evidence={ECO:0000250|UniProtKB:P10614};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- PATHWAY: Steroid biosynthesis; zymosterol biosynthesis; zymosterol from
CC       lanosterol: step 1/6.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U72657; AAC49811.2; -; Genomic_DNA.
DR   EMBL; U72658; AAC49812.2; -; mRNA.
DR   EMBL; U83840; AAC49801.2; -; Genomic_DNA.
DR   AlphaFoldDB; O14442; -.
DR   SMR; O14442; -.
DR   UniPathway; UPA00770; UER00754.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0008398; F:sterol 14-demethylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW.
DR   CDD; cd11042; CYP51-like; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002403; Cyt_P450_E_grp-IV.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   PANTHER; PTHR24304:SF2; 24-HYDROXYCHOLESTEROL 7-ALPHA-HYDROXYLASE; 1.
DR   PANTHER; PTHR24304; CYTOCHROME P450 FAMILY 7; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00465; EP450IV.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   2: Evidence at transcript level;
KW   Heme; Iron; Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding;
KW   Monooxygenase; Oxidoreductase; Steroid biosynthesis; Steroid metabolism;
KW   Sterol biosynthesis; Sterol metabolism.
FT   CHAIN           1..524
FT                   /note="Eburicol 14-alpha-demethylase"
FT                   /id="PRO_0000052010"
FT   BINDING         469
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   VARIANT         136
FT                   /note="Y -> F (in strain: PAZ11; resistant to triadimenol;
FT                   a sterol demethylation-inhibiting fungicide)"
FT                   /evidence="ECO:0000269|PubMed:9300816"
SQ   SEQUENCE   524 AA;  59840 MW;  24BE154B176CE09A CRC64;
     MYIADILSDL LTQQTTRYGW IFMVTSIAFS IILLAVGLNV LSQLLFRRPY EPPVVFHWFP
     IIGSTISYGI DPYKFYFDCR AKYGDIFTFI LLGKKVTVYL GLQGNNFILN GKLKDVNAEE
     IYTNLTTPVF GRDVVYDCPN SKLMEQKKFM KTALTIEAFH SYVTIIQNEV EAYINNCVSF
     QGESGTVNIS KVMAEITIYT ASHALQGEEV RENFDSSFAA LYHDLDMGFT PINFTFYWAP
     LPWNRARDHA QRTVARTYMN IIQARREEKR SGENKHDIMW ELMRSTYKDG TPVPDREIAH
     MMIALLMAGQ HSSSSTSSWI MLWLAARPDI MEELYEEQLR IFGSEKPFPP LQYEDLSKLQ
     LHQNVLKEVL RLHAPIHSIM RKVKNPMIVP GTKYVIPTSH VLISSPGCTS QDATFFPDPL
     KWDPHRWDIG SGKVLGNDAV DEKYDYGYGL TSTGASSPYL PFGAGRHRCI GEQFATLQLV
     TIMATMVRFF RFRNIDGKQG VVKTDYSSLF SMPLAPALIG WEKR
//
DBGET integrated database retrieval system